🌍The Next Web (TNW)•Mar 10, 2026Stalecollected in 28m

Breakout Ventures Closes $114M AI Science Fund

Post LinkedIn

🌍Read original on The Next Web (TNW)

#funding#ai-biology#vc-sciencebreakout-ventures-fund-iiibreakout-venturesthiel-foundation

💡$114M fund bets big on AI+bio startups—key signal for science founders

⚡ 30-Second TL;DR

What Changed

Closed $114M Fund III, largest fund yet

Why It Matters

This large fund signals robust VC interest in AI-biology convergence, creating fundraising opportunities for AI founders in science. It highlights a shift toward interdisciplinary AI applications in biotech.

What To Do Next

Pitch your AI-biology startup to Breakout Ventures via their website.

Who should care:Founders & Product Leaders

Key Points

•Closed $114M Fund III, largest fund yet
•Targets AI-powered science startups fusing AI and biology
•San Francisco firm founded by Lindy Fishburne from Thiel Foundation

🧠 Deep Insight

Background and context from public sources — not the original article. 6 sources cited.

🔑 Enhanced Key Takeaways

•Breakout Ventures evolved from Breakout Labs, a philanthropic program launched by the Thiel Foundation in November 2011 that provided convertible grants (up to $350,000) for speculative early-stage scientific research, establishing a pipeline of science-driven founders before transitioning to traditional venture capital in 2016[1][3]
•The firm's investment strategy leverages deep technical expertise across biology, chemistry, and technology sectors, with the team including PhD-level partners (Dana Watt, Nima Ronaghi) and venture partners with specialized scientific backgrounds, enabling evaluation of complex AI-biology integration[6]
•Breakout Ventures' portfolio spans multiple deep-tech domains including cancer treatment (Noetik), medical diagnostics (Cytovale), RNA therapeutics (EnPlusOne Biosciences), and catalysis innovation (Corpernic Catalysts), demonstrating diversification beyond pure AI applications[3]

🔮 Future ImplicationsAI analysis grounded in cited sources

AI-biology convergence is becoming a core venture thesis rather than a niche specialty

Breakout Ventures' $114M fund dedicated to AI-powered science represents institutional validation that AI-driven biological discovery has matured from experimental to fundable at scale.

Founders with dual AI and biology expertise are becoming a scarce, high-value resource

The firm's explicit targeting of founders who master both domains suggests this skill intersection is rare enough to be a competitive advantage and fund differentiation strategy.

⏳ Timeline

2011-11

Breakout Labs launched by Thiel Foundation to fund speculative early-stage scientific research with convertible grants

2012-04

Breakout Labs announced first batch of grantees

2016

Breakout Ventures founded as separate entity to provide traditional venture capital to science-driven companies, leveraging Breakout Labs pipeline

2017-09

Breakout Ventures closed debut fund at $60 million with limited partners including Thiel Foundation, DCVC co-founders, and family offices

📎 Sources (6)

Factual claims are grounded in the sources below. Forward-looking analysis is AI-generated interpretation.

🌍Read original article on The Next Web (TNW)

📰

Weekly AI Recap

Read this week's curated digest of top AI events →

👉Related Updates

Same topic

Explore #funding

Same product

AI-curated news aggregator. All content rights belong to original publishers.
Original source: The Next Web (TNW) ↗

This is a summary, not the original. Read the source, or get the weekly briefing.

Weekly AI briefing

One email a week. Unsubscribe anytime.

⚡ 30-Second TL;DR

Key Points

🧠 Deep Insight

🔑 Enhanced Key Takeaways

🔮 Future ImplicationsAI analysis grounded in cited sources

⏳ Timeline

📎 Sources (6)

👉Related Updates

Anthropic IPO Could Top $100B in Funding

AI-Trained Skin Predicts New Drug Compounds

AI Data Centres Trigger Car Component Shortages

768 Leaked AWS Keys Still Grant Dangerous Access